Randomised controlled clinical trial to evaluate the add on effect of asthapad rajat shalaka agnikarma in management of katigat vata w.s.r. to lumbar spondylosis.

Title - RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE ADD ON

EFFECT OF ASHTAPAD RAJAT SHALAKA AGNIKARMA IN MANAGEMENT OF

KATIGAT VATA W.S.R.TO LUMBAR SPONDYLOSIS.

Null hypothesis [H0] - Ashtapad rajat shalaka agnikarma is not significantly effective in katigata vata

with special reference to lumbar spondylosis .

Alternate hypothesis [H1] - Ashtapad rajat shalaka agnikarma is significantly effective in katigata vata

with special reference to lumbar spondylosis.

Study design - Randomized controled clinical trial

Inclusion criteria -

Clinical features of Katigata Vata / lumbar spondylosis confirmed by Xray

Patients of either sex between 30 to 60 years.

Willing & able to participate and complete the study.

Selection will be irrespective of gender, religion and other socioeconomic status.

Exclusive criteria-

History of spinal surgery, fractures, malignancy, or systemic illness

Pregnant and lactating women

Tuberculosis of spine

Contraindications for Agnikarma (skin disorders, bleeding disorders,

uncontrolled diabetes, etc.)

Sample size- 70 (35 for each group)

Sample population -

Patients coming to OPD, IPD parent ayurveda rugnalaya and camps in

the periphery of parent research center and hospital with Katigata vata(Lumbar spondylosis)

Group A- Yograj guggul vati + Dashmularistha +Ashtapad Rajat Shalaka agnikarma

Group B- Yograj guggul vati + Dashmularistha

Total duration of therapy is 10 days. The mode of drug administration will be oral route and local agnikarma therapy

Follow up - Follow up will be on 7th ,10th day

Result - Result will be drawn as per assessment criteria and statistical analysis.